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Oxidative stress (e.g., increased hydrogen peroxide [H2O2] levels) and dicarbonyl 
stress (e.g. increased methylglyoxal [MG]) serve as initiators for the pathogenesis of 
cardiovascular diseases and diabetic complications. Increased H2O2-derived free radicals 
and MG can be highly reactive and attack cellular components resulting in cell damage 
and even cell death. Normally, endogenous antioxidants and glyoxalase degrade H2O2 
and MG, respectively. Additionally, autophagy facilitates the break-down of damaged 
cellular components allowing the components to be recycled by the cells. Researchers are 
still unclear about whether autophagy exacerbates cell damage or protects cells from 
higher doses of H2O2 and MG. This study investigated cell damage and autophagy 
changes when rat cardiac H9c2 myoblasts were treated with H2O2 or MG. Moreover, 
autophagy enhancing or inhibiting drugs were tested to evaluate their effects on H2O2- or 
MG-induced cell damage. We found that H2O2 (100 - 600 M, n=4) dose-dependently 
decreased cell viability as determined by measuring live cell dehydrogenase activity. 
H2O2 (600 M, n=4) decreased cell viability to 30  5% of the control. Similarly, MG 
(400 - 1200 M, n=5) decreased cell viability in a dose-dependent manner. MG (1200 
M, n=5) decreased cell viability to 30  6% of the control. These results were further 
confirmed with the use of calcein staining, which contained calcein-AM for labeling live 
cells. By using Cyto ID autophagy detection dye, we found that H9c2 cells exhibited 
higher autophagy after incubation of H2O2 (100 - 600 M, n=2) or MG (400 - 1200 M, 
n=2), for 1 and 4 hours, and 1 and 24 hours, respectively. Intracellular ROS was also 
detected, and the data suggested that ROS levels increased as the dose of H2O2 and MG 
increased. Experimentation using autophagy regulatory drugs revealed that trehalose (500 
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M - 100 mM, n=4), an autophagy enhancer, increased cell viability at 24 hours for cells 
exposed to H2O2 (600 M), and increased cell viability at 1, 4, and 24 hours for cells 
exposed to MG (1200 M) compared to the positive controls (600 M H2O2 or 1200 M 
MG). Trehalose (100 mM, n=4) increased cell viability by 78  31% in MG-treated cells 
when compared to cells treated with MG (1200 M) alone at one-hour post treatment. 
Trehalose also decreased intracellular ROS levels. Rapamycin (100 nM – 20 M), 
another autophagy enhancer, reduced intracellular ROS levels in cells exposed to H2O2 
and cells exposed to MG, but generally did not increase cell viability for cells exposed to 
600 M H2O2 or 1200 M MG. 3-methyladenine (3-MA), an autophagy inhibitor, 
increased intracellular ROS levels. 3-MA (50 – 10,000 M) provided no increase in cell 
viability compared to H2O2 (600 M), but for MG at 1 and 4 hours, 3-MA did increase 
cell viability. Our data suggests that trehalose has potential to provide protection against 
H2O2 or MG-induced damage, while rapamycin does not. 3-MA seems to provide 
protection against MG, but not H2O2. 
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Cardiovascular disease (CVD) is the main cause of death for people of all races 
and ethnicities in the United States. About one in every four deaths in America can be 
attributed to CVD.  Risk factors such as high cholesterol, high blood pressure, and 
smoking can lead to CVD and stroke; a little less than half of Americans have at least one 
of the three risk factors. Medical conditions, such as diabetes, can increase the risk of a 
person suffering from CVD. Certain lifestyle choices can also increase the chances of 
CVD occurring, such as an unhealthy diet, being overweight, abusing alcohol, etc. 
(Center for Disease Control, 2019). Under normal conditions, the heart will pump blood 
to the rest of the body so that nutrients and oxygen can reach organs for proper 
functioning. Many cardiovascular diseases impede this blood flow, therefore stopping the 
nutrients and oxygen from getting to their needed locations in the body. CVDs prevent 
the flow of blood by damaging and reshaping blood vessels; this can occur in the form of 
making the vessels harder and narrower therefore reducing blood flow (Cervantes et al, 
2017). Oxidative stress, which serves as an early causative factor of CVDs, can damage 
cardiomyocytes, therefore decreasing heart function even more (Cervantes et al, 2017). 
1.1 Oxidative Stress 
Under normal conditions, reactive oxygen species (ROS) are formed 
endogenously as by-products of cellular metabolism mechanisms. ROS levels are low 
when cellular function is not disrupted. One way that ROS levels are maintained at a low 
level is by cellular antioxidant mechanisms. If ROS are overproduced, they can initiate a 
vicious cycle that facilitates the pathogenesis of various diseases, such as cancer, 
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diabetes, CVDs, and others. ROS threaten cells by reacting with DNA, proteins, and 
lipids and causing damage to them. Overproduction of ROS that exceeds the ability of the 
antioxidant mechanisms of the cell causes oxidative stress. When a cell is under oxidative 
stress, stress response mechanisms (e.g., antioxidant enzymes upregulation) are activated 
to help the cell adapt to the stress or resist it. Some of the activated stress response 
mechanisms are used to help the cell survive, while others induce cell death (Martindale 
and Holbrook, 2002; Navarro-Yepes et al, 2014).      
ROS can contribute to the pathophysiology of cardiovascular disease. Damaged 
myocardiocytes can produce elevated concentrations of ROS within their mitochondria. 
Long-term ROS production in the mitochondria can cause mitochondrial DNA damage 
and mitochondrial functional decline (Tsutsui et al, 2011). This means that the 
myocardiocytes will no longer be receiving the necessary energy needed for normal 
function which can lead to cell death. High levels of ROS can also signal for apoptosis, a 
type of programmed cell death in myocardiocytes (Tsutsui et al, 2011). The more 
myocardiocytes die as a result of oxidative stress, the less the heart is able to function 
properly and pump blood to the rest of the body (Tsutsui et al, 2011).   
  
1.1.1 Reactive Oxygen Species  
ROS are small molecules that are highly reactive, since they can bind to cellular 
biomolecules disrupting normal function (Rezda-Dutordoir and Bates, 2016). The 
production of ROS is generally in equilibrium with antioxidant reactions keeping the 
ROS levels at an optimum level in the cell under physiological conditions. Moreover, low 
amounts of ROS are needed for normal cell functioning. ROS helps cell cycle 
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progression, cell proliferation, cell differentiation, and cell migration along with many 
other beneficial functions (Rezda-Dutordoir and Bates, 2016). ROS can activate cell 
signaling pathways and transcription factors, such as phosphoinositide 3-kinase (PI3K). 
PI3K is important in signaling for the activation of autophagy (Rezda-Dutordoir and 
Bates, 2016), which will be discussed later.  
ROS can be formed by the cell both exogenously and endogenously. Exogenous 
sources of ROS production include ultraviolet light, ionizing radiation, and xenobiotics 
(Milkovic et al, 2019). Endogenous ROS is often in the form of superoxide, which is 
derived from in the mitochondrial electron transport chain (ETC). The main sites in the 
ETC of superoxide production are complexes I and III (Rezda-Dutordoir and Bates, 
2016). In the ETC, about 2-3% of free electrons leak out and transfer to molecular 
oxygen forming superoxide radicals (Rezda-Dutordoir and Bates, 2016). Superoxide can 
also be formed by NADPH oxidases and xanthine oxidase located at the membrane 
(Rezda-Dutordoir and Bates, 2016). Superoxide is converted into H2O2 by the enzyme 
superoxide dismutase. High concentrations of H2O2 can form hydroxyl radicals (OH
.)  
through the Fenton reaction (Rezda-Dutordoir and Bates, 2016). Hydroxyl radicals are 
quite dangerous since they are very reactive with biological macromolecules. To avoid 
the dangers that hydroxyl radicals can cause, H2O2 is converted to H2O by catalase 
(Rezda-Dutordoir and Bates, 2016).   
1.1.2 Hydrogen Peroxide-induced Oxidative Stress, Cell Damage, and Disease 
As mentioned before, superoxide radicals form mostly in the mitochondria in the 
ETC. Superoxide radicals are often catalyzed by a nonenzymatic electron transfer 
reaction (Phaniendra et al, 2015). Superoxide radicals generally have low reactivity with 
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biomolecules. Their toxicity is more prominent through production of secondary free 
radicals (Phaniendra et al, 2015). For example, when two superoxide radicals react with 
one another in a dismutation reaction, one radical is oxidized to form oxygen, while the 
other superoxide radical is reduced to form H2O2 (Phaniendra et al, 2015). H2O2 can be 
much more damaging, because it can be converted into a hydroxyl radical when reacted 
with superoxide. Hydroxyl radicals are formed by the Fenton reaction, as previously 
mentioned. The Fenton reaction occurs when H2O2 reacts with metal ions, such as Fe2+ or 
Cu+ (Phaniendra et al, 2015). Fe2+ and Cu+ are often bound to different proteins, such as 
ferritin, which is an intracellular protein that stores iron, and ceruloplasmin, which is a 
copper-carrying protein found in the plasma (Phaniendra et al, 2015). When there is a 
high concentration of superoxide radicals, this stress will cause ferritin to release free 
Fe2+, and the released Fe2+ will then participate in the Fenton reaction with H2O2 forming 
hydroxyl radicals (Phaniendra et al, 2015). Hydroxyl radicals cause more damage to the 
cell than any other ROS and react very strongly with inorganic and organic molecules. 
Hydroxyl radicals often react with DNA, proteins, lipids, and carbohydrates; when these 
structures in the cell are damaged, it can be detrimental to the cell (Phaniendra et al, 
2015).     
Oxidative stress caused by H2O2 can have a negative impact on cardiomyocyte 
DNA and ATP levels. Oxidative stress can cause the loss of purine and pyrimidine 
nucleotides in cardiomyocyte DNA; this can lead to ATP and phosphocreatine depletion 
(Janero et al, 1993). Phosphocreatine is important for transferring high energy phosphates 
to ADP. When phosphocreatine is depleted, ATP will not be able to form which will in 
turn provide less energy for cardiomyocytes eventually causing cardiomyocyte death 
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(Janero et al, 1993). A study was done to portray how H2O2 effects the energy levels in 
cardiomyocytes. The rate of nucleotide loss was dependent on the dosage of H2O2 (50 
M - 1 mM). At higher concentrations of H2O2, significant energy was lost in 
cardiomyocytes as a result of phosphate loss from nucleotide deletions. The only way to 
prevent ATP loss during H2O2-induced oxidative stress was dismutation of H2O2 (Janero 
et al, 1993). This is why H2O2 can be so detrimental to cardiomyocytes and the heart as a 
whole.    
H2O2 increases under disease conditions, such as ischemia/reperfusion injury and 
diabetes (Slezak et al, 1995). A study was done to examine amounts of H2O2 present in 
myocardial cells of rats when the rat heart was under ischemia/reperfusion conditions. 
Within minutes of ischemia, the rat’s heart lost its contractile ability, and the myocardial 
H2O2 levels increased 250% compared to control levels. Then, in the early stages of 
reperfusion, H2O2 concentrations were increased 600% compared to the control (Slezak et 
al, 1995). High blood sugar in diabetes also increases H2O2 concentrations (Ellis et al, 
2000). A study was done comparing the amounts of plasma H2O2 levels in rats with 
diabetes and rats without diabetes. The rats with diabetes contained about twice as much 
H2O2 in their blood vessels than the rats that did not have diabetes (Ellis et al, 2000). 
1.1.3 Methylglyoxal (MG)-induced Dicarbonyl Stress and Cell Damage 
MG, a dicarbonyl compound, is a product of cellular metabolism. It is found in all 
cells. MG is produced via both enzymatic and non-enzymatic pathways (Allaman et al, 
2015). MG can be made as a by-product in the pathways of protein synthesis and fatty 
acid metabolism, but glycolysis is the most significant endogenous source of MG 
production (Allaman et al, 2015). In the glycolysis pathway, MG is produced by the 
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fragmentation of glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate 
(DHAP) (Allaman et al, 2015). Normally, MG concentrations are very low in cells 
reaching up to no more than 300 M. However, high MG levels can arise when the 
precursors in the production pathway are elevated (Allaman et al, 2015). For example, in 
diabetics, blood glucose concentrations are high producing high G3P and DHAP levels, 
therefore increasing MG concentrations above normal physiological concentrations 
(Allaman et al, 2015). Normally, MG is detoxified by glyoxalase I and II, which helps 
convert MG to D-lactate. D-lactate is then metabolized to pyruvate by D-lactate 
dehydrogenase (Bhowal et al, 2020).     
When MG accumulate due to increased production or decreased detoxification, 
dicarbonyl stress occurs. Dicarbonyl stress is often known to occur with metabolic 
diseases, such as diabetes (Thornalley, 2008). MG is the most reactive dicarbonyl 
metabolite. MG is a glycating agent meaning that MG is involved in covalently attaching 
sugars to proteins and other cellular components, and as a result can induce cellular 
dysfunction by disrupting the normal function of these cellular components (Thornalley, 
2008). Protein glycation consists of a complex series of reactions named collectively as 
the Maillard reaction (Thornalley, 2008). The Maillard reaction occurs in all tissues and 
bodily fluids. Later stages of glycation form what is known as advanced glycation end-
products (AGEs), which can change protein structure, therefore changing its function 
(Thornalley, 2008). When MG reacts with proteins it forms AGE residues. When MG 
interacts with proteins the bond is irreversible (Thornalley, 2008). Specifically, MG 
reacts with the amino acid arginine to produce AGEs called hydroimidazolones 
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(Thornalley, 2008). AGEs have been shown to increase ROS levels as well as reduce 
catalase activity (Chen et al, 2018).  
High levels of MG can be toxic to the cell because ROS production is increased. 
MG glycation often targets mitochondrial proteins. Glycation of these proteins causes an 
increase in ROS production (Desai et al, 2010). The ROS then react with other proteins, 
lipids, DNA, etc. therefore altering their structures and causing an alteration in function. 
High concentrations of ROS in the mitochondria will also alter the mitochondrial 
permeability, therefore disrupting proper mitochondrial function (Desai et al, 2010). MG 
also decreases the activity of superoxide dismutase, which is the first line of defense 
against oxidative stress and functions by converting superoxide to H2O2 (Desai et al, 
2010).  
1.1.4 Methylglyoxal Impact on Heart Cell Function 
People who have diabetes are often at high risk for developing heart failure 
(Papadaki et al, 2018). MG is increased in diabetics, therefore increasing AGEs; AGEs 
are understood to be the pathophysiological link between the two diseases (Papadaki et 
al, 2018). A study compared MG modification levels in myofilaments of patients with 
diabetes and heart failure and in myofilaments of patients without diabetes and heart 
failure. The results showed that patients with diabetes and heart failure had an increase in 
MG modifications, therefore decreasing the function of myofilaments in heart cells 
(Papadaki et al, 2018).  
Another study tested how MG affects a molecule called thioredoxin (Trx). Trx is 
cytoprotective and antiapoptotic molecule. It is important for cell survival. Inactivation of 
Trx has been known to be related to cardiovascular injury (Liu et al, 2010). Trx 
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inactivation can occur when AGEs glycate the molecule, since Trx is quite susceptible to 
glycation (Liu et al, 2010). An experiment was done to see if MG would cause Trx-
glycative inactivation, therefore making cardiomyocytes more likely to undergo 
ischemia/reperfusion injury. When human Trx was incubated with MG, Trx glycation 
occurred rendering the molecule inactive, therefore making cardiomyocytes more prone 
to ischemia/reperfusion injury (Liu et al, 2010).  
1.2 Autophagy 
When cells are under stress, autophagy can be activated to cope with the stress. 
Autophagy is a term used to describe the process of a cell’s damaged cytoplasmic 
components being degraded inside of a lysosome-fused vacuole. There are three types of 
autophagy: macroautophagy, microautophagy, and chaperone-mediated autophagy 
(Mizushima, 2007). The term “autophagy” is most often synonymous with 
macroautophagy (Mizushima, 2007). Generally speaking, the mechanism of autophagy 
begins with the formation of a phagophore, which then matures into a double-membraned 
autophagosome. The autophagosome and lysosome then fuse together forming what is 
known as an autolysosome. The autolysosome is where cellular components are broken 
down by the lysosome’s degradative enzymes. The broken-down cellular components can 
then be recycled to establish homeostasis within the cell (Navarro-Yepes et al, 2014). 
This is a basic overview of the autophagy process; however, a more detailed description 
will be discussed in the following section.     
Autophagy has been shown to have a vast range of purposes. It has physiological 
benefits as well as pathophysiological benefits. Some of the pros of autophagy include 
helping the cell adapt when the cell is not receiving adequate amounts of nutrients for 
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survival, clearing damaged intracellular proteins and organelles, tumor suppression, and 
more (Mizushima, 2007).  
1.2.1 Autophagy Mechanism   
The autophagy process begins with a membrane, which is known as a 
phagophore, and it is thought to be derived from the lipid bilayer of the endoplasmic 
reticulum or the Golgi apparatus (Glick et al, 2010). The phagophore expands and gathers 
intracellular materials, such as proteins, carbohydrates, lipids, etc. forming the 
autophagosome. The lysosome’s proteases are then able to degrade the damaged 
macromolecules collected in the autophagosome that were gathered earlier in the process 
(Glick et al, 2010). The lysosome also has enzymes called permeases along with other 
transporters that function to export the degraded amino acids, monosaccharides, and other 
monomers back into the cytoplasm for the cell to reuse in order to build new 
macromolecules (Glick et al, 2010).    
Autophagy is a complex process with many components, which can be seen in 
Figure 1.1. There are five significant stages: 1) nucleation (phagophore formation), 2) 
autophagy related protein 5-autophagy related protein 12 (Atg5-Atg12) conjugation, 3) 
light chain 3 (LC3) processing, 4) selection of cargo for degradation, and 5) 
autophagosome and lysosome fusion (Glick et al, 2010). 
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Figure 1.1 Autophagy Mechanism and the required proteins involved in initiating the formation 
of the phagophore, autophagosome, and autolysosome.  
(Hansen et al, 2018). 
 
Multiple signaling events take place in order for nucleation to occur. In yeast 
cells, Atg1 kinase works with Atg13 and Atg17 to form a phagophore. In mammalian 
cells, Ulk-1 is analogous with the yeast’s Atg1 kinase (Glick et al, 2010). Ulk-1 functions 
to signal for autophagy to begin. Class III phosphatidylinositol-kinases (PI3K) are 
involved in autophagy and phagophore formation (Glick et al, 2010). One of the most 
notable class III PI3K proteins is vesicular protein sorting 34 (Vps34). When Vps34 is 
complexed with Beclin-1 and other regulatory proteins, it is involved in autophagy 
nucleation (Glick et al, 2010). Vps34 uses phosphatidylinositol as a substrate to form 
phosphatidylinositol triphosphate (PI3P). PI3P is required for phagophore elongation, and 
it also recruits other Atg proteins to the phagophore (Glick et al, 2010). Vps34 and 
Beclin-1 interaction increases the levels and activity of PI3P (Glick et al, 2010).   
Atg5-Atg12 conjugation is important for elongation and closure of the 
autophagosome (Glick et al, 2010). It is a multistep process that begins with Atg7 binding 
to Atg12 in an ATP-dependent manner. Atg10 then is involved with mediating the 
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linkage between Atg12 to Atg5 (Glick et al, 2010). The conjugated Atg5-Atg12 complex 
then combines with Atg16L dimers to form an Atg5-Atg12-Atg16L complex that is 
involved with expanding the phagophore (Glick et al, 2010). Atg5-Atg12-Atg16L 
complex recruits LC3-II to assist in growing the phagophore and inducing the structure’s 
curve (Glick et al, 2010). Once the phagophore completes its formation into the 
autophagosome, the Atg5-Atg12-Atg16L complex dissociates from the membrane (Glick 
et al, 2010).  
LC3 is a microtubule-associated protein (Glick et al, 2010). LC3 is expressed in 
the cytosols of most cells. When autophagy is initiated, Atg4 proteolytically cleaves LC3 
to form LC3-I (Glick et al, 2010). LC3-I is then activated in an ATP-dependent manner. 
Once LC3-I is activated, it is transferred to Atg3, then phosphatidylethanolamine (PE) is 
conjugated to glycine on LC3-I converting it to LC3-II (Glick et al, 2010). LC3-II is then 
recruited and integrated into the developing phagophore by the Atg5-Atg12-Atg16L 
complex (Glick et al, 2010). LC3-II is located on both the outer and inner surface of the 
autophagosome, and it functions to select the cargo in the cell’s cytoplasm that needs to 
be degraded as well as hemifusion of the autophagosome’s membranes (Glick et al, 
2010). LC3 is a good protein to quantify to determine rate of autophagy since synthesis of 
LC3 increases during autophagy (Glick et al, 2010). 
Autophagy had been thought to be a somewhat random process in the sense that 
the cargo engulfed in the autophagosome is indiscriminately gathered. Further research 
has shown that the membrane of the growing phagophore can actually interact with 
proteins, carbohydrates, lipids, and organelles to selectively uptake the cargo that requires 
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breakdown. LC3-II acts as a receptor to help determine which cytosolic materials should 
be taken in by the phagophore for degradation (Glick et al, 2010). 
When the autophagosome formation is complete and the cargo deemed for 
degradation is carried within the structure, the next step in the process is fusion with the 
lysosome to form an autolysosome. Lysosomal proteases are delivered to the 
autophagosome and are then able to degrade the proteins, carbohydrates, lipids, and 
anything else stored inside the vesicle (Glick et al, 2010). 
1.2.2 Autophagy, Oxidative Stress, and Cardiovascular Diseases 
Autophagy actually has been proven to be beneficial in preventing CVDs, but it 
also has been proven to be dangerous. Autophagy has an adaptive phase and also a 
maladaptive phase (Mei et al, 2015). Adaptive autophagy in response to oxidative stress 
enhances myocardiocytes survival by getting rid of damaged organelles and recycling 
macromolecules (Mei et al, 2015). On the other hand, maladaptive autophagy is 
detrimental to myocardiocytes because there is an excess of self-digestion, and essential 
organelles and proteins get broken down. Maladaptive autophagy can also induce 
apoptosis (Mei et al, 2015). This can enhance the damage of CVDs. 
Most studies have suggested that oxidative stress can induce autophagy. In 
contrast, antioxidant treatment can reduce autophagy related to oxidative stress. One 
study led by Danyong Li and Jingcheng Yu showed that H2O2 induced cell death by 
apoptosis in a dose-dependent (100 M-1000 M) and time-dependent (2 - 12 hours) 
manner in Mc3T3-E1 osteoblasts (Li et al, 2017). Moreover, cells exhibited a significant 
increase in autophagy after incubation with 500 M and 1000 M H2O2 for 8 hours. By 
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contrast, pretreating cells with catalase for one hour significantly reduced autophagy; 
however, cell viability after catalase treatment was not investigated in the study. The 
study also showed that application of an autophagy enhancer (e.g., rapamycin) reduced 
oxidative stress and cell apoptosis. Application of an autophagy inhibitor (e.g., 3-
methyladeneine) significantly increased cell death when compared to H2O2 alone (Li et 
al, 2017).  
On the other hand, some studies suggest that autophagy can facilitate cell 
apoptosis under oxidative stress. Ji Haye Ha and other researchers found that H2O2 
dramatically induced H9c2 cell damage, and using propofol or autophagy inhibitors (e.g., 
wortmannin) can protect cells against H2O2-induced cell damage. More interestingly, 
H2O2 increased acidic autophagy vacuoles, whereas propofol largely reduced autophagy 
and its associated proteins (Ha et al, 2012). This study provides evidence of autophagy 
inducing more cell damage under oxidative stress.   
MG has been known to increase the rate of autophagy just as H2O2 does. 
Specifically, the AGEs formed as a result of MG reacting with proteins are what cause 
the increase in the autophagy rate (Verma and Manna, 2016). AGEs will increase 
autophagy in various cell types as long as the cell has the receptor for AGE (RAGE), 
which cardiomyocytes do possess (Verma and Manna, 2016). A study was done to 
determine whether AGE would induce and increase autophagy in HepG2 cells, which, 
like cardiomyocytes, have RAGE (Verma and Manna, 2016). AGE (100 g/mL) was 
added to the HepG2 cell line, and the cells were then stained with Monodansylcadaverine 
(MDC), which fluoresces in autophagy vacuoles. Results showed that MCD-stained 
HepG2 cells were consistently more fluorescent when exposed to AGE compared to the 
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control. This means that there were more autophagosomes formed as a result of AGEs. 
Using western blot analysis, autophagy proteins were analyzed when the cell line was 
exposed to AGE. AGE increased autophagy in a dose- and time-dependent manner as 
shown by an increase in the concentration of LC3 protein. These findings therefore 
support the claim that MG increases the rate of autophagy (Verma and Manna, 2016).    
Some studies suggest that impaired autophagy may contribute to heart 
hypertrophy. Jia-Pu Wang accompanied by other researchers found that H9c2 cells 
treated with lower concentrations of H2O2 (10 - 50 M) for 48 hours inhibited autophagy 
and accompanied cardiac myocyte hypertrophy. When 3-methyladenine (3-MA), an 
autophagy inhibitor, was also introduced to the H9c2 cells, even higher amounts of 
hypertrophy were noticed. In contrast, antioxidant administration reduced oxidative stress 
and cardiac hypertrophy. The results of the study showed that introducing antioxidants or 
restoring the myocardiocytes autophagy mechanisms could be useful in preventing 
myocardial hypertrophy (Wang et al, 2018).  
In summary, there exists disparity regarding the role of autophagy under oxidative 
stress. Is autophagy helpful to cells, or is it harmful to the cells? It is also important to 
understand how to regulate the process of autophagy properly. With a better 
understanding of autophagy, the process could be used as a therapeutic method to treat or 
prevent CVD.  
1.3 Autophagy Enhancers and Inhibitors  
Introducing autophagy enhancers and inhibitors can help to understand the role of 
autophagy in human diseases. Adding autophagy enhancers and inhibitors to cells under 
oxidative stress can further our understanding of the mechanism behind autophagy and 
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help determine if the process will actually decrease oxidative stress in the cells or not. 
There are various autophagy enhancing and inhibiting drugs that target various proteins 
or receptors in the autophagy process. Enhancers used in this project include rapamycin 
and trehalose. The inhibitor used in this project is 3-MA. 
1.3.1 Rapamycin  
 Rapamycin is an autophagy enhancing drug that targets the autophagy inhibitor 
protein mammalian target of rapamycin (mTOR) (Yang et al, 2013). Rapamycin binds 
fk506-binding protein 12kDa (FKBP12) forming a complex that inhibits mTOR activity 
(Yang et al, 2013). mTOR is one of the main regulatory pathways of autophagy. mTOR 
acts as an inhibitor of the autophagy process (Yang et al, 2013). Introduction of 
rapamycin works to inhibit mTOR and enhance Ulk-1’s kinase activity, therefore 
signaling for autophagy to proceed (Yang et al, 2013).  
1.3.2 Trehalose 
 Trehalose is a disaccharide sugar found in organisms, such as bacteria, plants, 
insects, fungi, and other invertebrates. It is not naturally found in mammals 
(Hosseinpour-Moghaddam et al, 2018). Trehalose prevents protein denaturation in these 
organisms, so it helps protect against various stress conditions (Hosseinpour-Moghaddam 
et al, 2018). Trehalose, when introduced into mammals, works as an enhancer of 
autophagy. Trehalose works by inhibiting transport of glucose and fructose through 
glucose (GLUT) transporters (Mardones, Rubinsztein, and Hetz, 2016). This forces the 
cell into a starvation-like state that will then signal the autophagy process to take place. 
Autophagy is stimulated through AMP-activated protein kinase (AMPK) and activation 
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of Ulk-1 (Mardones, Rubinsztein, and Hetz, 2016). This is an mTOR-independent 
mechanism (Mardones, Rubinsztein, and Hetz, 2016). 
1.3.3 3-Methyladenine 
 3-MA is an autophagy inhibitor. 3-MA inhibits autophagy by inhibiting the class 
III PI3K complex. Inhibiting class III PI3K will then block PI3P from forming (Wu et al, 
2010). Other Atg proteins would normally recruit PI3K to signal for the initiation of 
autophagy, but since PI3K is blocked in this case, initiation does not occur, therefore 
autophagy ceases (Wu et al, 2010).  
1.3.4 Previous Study of Autophagy during I/R in the lab 
 One of my peers, Aloysius Ibe, did a research study on a similar topic. In fact, this 
particular project is an extension of his project. His project’s focus was on determining if 
autophagy benefits the heart when an ischemic/reperfusion insult takes place. He used the 
same autophagy regulatory drugs as I did for this project: rapamycin, trehalose, and 3-
MA. Aloysius’s project tested the effects of the autophagy enhancers (rapamycin, 
trehalose) and the autophagy inhibitor (3-MA) on heart function and infarct size after 
ischemia/reperfusion. The results from his study suggested that autophagy enhancers 
reduced Ischemia/reperfusion injury.  
 Similarly to Aloysius’s project, our project uses the same autophagy regulatory 
drugs (rapamycin, trehalose, and 3-MA). Instead of focusing on I/R injury and infarct 
sizes in particular, our project focused on reducing the levels of ROS in myocardiocytes 
that can be raised by diseases like I/R injury, CVDs, and diabetes. In our study, oxidative 
stress was induced by increasing concentrations of H2O2 or MG. We used the autophagy 
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regulatory drugs to determine whether enhancement of autophagy or downregulation of 
autophagy could appease the levels of ROS, therefore decreasing oxidative stress in 
myocardiocytes and reducing cardiac damage.   
1.4 Hypothesis 
We hypothesize that H2O2 and MG will decrease cell viability in a dose-
dependent and time-dependent manner and will also increase ROS and oxidative stress in 
cardiomyoblasts. We also hypothesize that enhancement of autophagy would help 









2.1 H9c2 Myoblast Cell Culture  
H9c2 cells were used for experimentation. In order to perform various 
experiments, the H9c2 cells required proper maintenance. The H9c2 cells needed to have 
a confluence of about 70-80%, otherwise the cell population would die out. To maintain 
the cell line, the cell culture required subculturing. Subculturing entailed discarding old 
medium containing the cells’ metabolic wastes, then washing the cell line with phosphate 
buffered saline (PBS). Once the cells were washed with PBS, 2.5% trypsin (Sigma 
Aldrich, St Louis, MO, USA) was added to the cells. Trypsin was necessary to allow the 
cells to free themselves from the bottom of the flask. The cell culture was then added to a 
collecting tube and centrifuged (1000rpm for 7 minutes). The supernatant was discarded 
after centrifuging, then new medium was added to the cells to achieve the desired 
concentration of 2 x 105 cells/mL. Thereafter, 100 µL of cell suspension (2 x 104 cells) 
were added to each well in a 96-well plate. After a 24-hour incubation period in the 96-
well plate, the cells were able to attach themselves to the bottom of the well and were 
ready for experimentation.    
2.2 Dose response: H2O2 and MG 
H2O2 (100 M - 600 M) was added to the cells to determine the effect of H2O2 
on H9c2 cell viability after the 1, 4, or 24-hr incubation period. Similarly, MG (400 M - 
1200 M) was added to the cells to determine the effect of MG on H9c2 cell viability 
after a 1, 4, or 24-hr incubation period.   
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2.3 H2O2 (600 M) + Rapamycin & MG (1200 M) +Rap 
Medium/solvent alone, H2O2 (600 M), and H2O2 (600 M) combined with 
rapamycin (25 nM - 20 M) were added to cells to determine if enhancement of 
autophagy by rapamycin could protect cells against H2O2-induced cell damage after a 1, 
4, or 24-hr incubation period.  
Similarly, medium/solvent alone, MG (1200 M), and MG (1200 M) combined 
with rapamycin (25 nM - 20 M) were added to cells to determine if enhancement of 
autophagy by rapamycin could protect cells against MG-induced cell damage after a 1, 4, 
or 24-hr incubation period.  
2.4 H2O2 (600 M) + Trehalose & MG (1200 M) + Trehalose 
Similar to the previous experiment, medium/solvent alone, H2O2 (600 M), and 
H2O2 (600 M) combined with trehalose (100 M - 100 mM) were added to cells to 
determine if enhancement of autophagy by trehalose could protect cells against H2O2-
induced cell damage after a 1, 4, or 24-hr incubation period.  
Medium/solvent alone, MG (1200 M), and MG (1200 M) combined with 
trehalose (100 M - 100 mM) were added to cells to determine if enhancement of 
autophagy by trehalose could protect cells against MG-induced cell damage after a 1, 4, 
or 24-hr incubation period.  
2.5 H2O2 (600 M) + 3-MA & MG (1200 M) + 3-MA 
 This experiment followed a similar format as the previous experiments; however, 
instead of using an autophagy enhancing drug, the autophagy inhibitor 3-MA was used. 
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Increasing concentrations of 3-MA (10 M - 10 mM) with H2O2 (600 M) or MG (1200 
M) was used to determine if inhibition of autophagy by 3-MA could protect cells 
against MG or H2O2-induced cell damage after a 1, 4, or 24-hr incubation period. 
2.6 Cell Counting Kit (CCK) Assay 
 CCK assay was used to determine the number of viable cells based on 
dehydrogenase activity in live cells. CCK uses tetrazolium salt, which is converted to 
formazan dye by intracellular dehydrogenase. Formazan dye is orange in color. The 
greater the amount of formazan dye, the higher the number of living cells there are and 
the darker the orange stain appears. After 1, 4, and 24-hr incubation, the old medium 
containing H2O2, MG, or H2O2/MG with enhancing or inhibiting drug was removed, and 
cells were washed with PBS twice. Then, 100 L of fresh medium was added, and 10 L 
of CCK assay buffer was put into each well. Absorbance was measured by an ELISA 
plate reader at 450 nm wavelength after 4-hr incubation with the CCK assay buffer.  The 
cell viability was expressed as a ratio by calculating absorbance relative to 
medium/solvent control or 600 M H2O2/1200 M MG control.    
2.7 Calcein-AM Staining  
Calcein-AM staining was used to stain live cells. Calcein-AM is a cell membrane 
permeable compound. Calcein generated by esterase activity in living cells, emits strong 
green fluorescence, so viable cells could be monitored as green fluorescent-stained cells 
under a fluorescent microscope. After drug treatment for 1, 4, or 24-hrs, medium was 
removed, then 100 L of PBS containing Calcein-MA (.001 M) was added to cells. After 
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a 30-minute incubation period, florescence was measured at 485 nm/535 nm. The ratio to 
the medium/solvent control or H2O2/MG control was calculated. 
2.8 Intracellular ROS detection by 2’,7’-dicholorofluorescein diacetate (DCFDA) 
DCFDA was used to detect intracellular ROS levels. DCFDA is a non-
fluorescent, cell permeable reagent. Once DCFDA enters the cell it is deacetylated by 
cellular esterases, then it is oxidized by intracellular ROS forming 2’,7’-
dichlorofluorescein (DCF). DCF is a fluorescent compound that can be detected using 
fluorescence spectroscopy.   
Before exposure to oxidative stress via H2O2 or MG, the H9c2 cells were washed 
twice with PBS and incubated for 45 minutes with 100 L DCFDA assay (.025 M) in 
working buffer (Hank’s Balances Salt Solution and Fetal Bovine Serum). After about 45 
minutes, the cells were washed again with PBS twice to remove the DCFDA from the 
incubating solution. The fluorescent DCF were then observed under the Fluoroskan 
Ascent CF scanner to get a base line reading before any treatment. After the reading, 
different concentrations of H2O2 and MG were added to the cell culture along with the 
autophagy enhancers and inhibitor described previously, which were prepared during the 
45-minute incubation period. After treatment, the fluorescent DCF were measured under 
the Fluoroskan Ascent CF scanner at 10 minutes post treatment, 30 minutes post 
treatment, 1hr post treatment, 2hr post treatment, 6hr post treatment, and 24hrs post 
treatment.   
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2.9 Cyto-ID Autophagy Detection Kit 
Cyto-ID (Enzo Life Sciences) was used to detect autophagy in live cells by 
fluorescence microscopy and Fluoroskan. Cyto-ID was a fairly quick method supplying 
quantitative data for monitoring autophagy activity at a cellular level. Cyto-ID involves a 
green fluorescent detection reagent that is excitable at 488 nm. This reagent fluoresces 
brightly in autophagy vesicles.  
The steps involved for Cyto-ID for a live cell analysis by fluorescence microplate 
reader are as follows: the H9c2 cells were seeded in a 96-well plate the day prior to the 
experiment. This allows the cells to attach overnight. The following day, the cells were 
treated with H2O2, MG, and the respective autophagy modulating drugs. After 1, 4, or 24 
hours of exposure to the treatment, the medium was removed and 100 L 1X Assay 
Buffer (9 mL deionized water and 1 mL 10X Assay Buffer from kit) was added to each 
well. The 1X Assay Buffer was then immediately removed and 100 L of dual color 
detection solution was added to each well. The dual color detection solution was made by 
combining 9 mL of 1X Assay Buffer with 18 L of CYTO-ID Green detection reagent 
and 9 L of Hoechst 33342 Nuclear Stain. Once the dual color detection solution was 
added to each well, the plate was wrapped in aluminum foil to protect it from the light 
and then incubated at 37 degrees Celsius for 30 minutes. After 30 minutes, the cells were 
washed twice with 200 L of 1X Assay Buffer in order to remove any extra dye in the 
wells. Then 100 L of 1X Assay Buffer was added to each well. The plate was then ready 
to be read in a fluorescence microplate reader. CYTO-ID Green detection reagent was 
read at 488 nm excitation, 527 nm emission. Hoechst 33342 Nuclear Stain was read at 
355 nm excitation, 490 nm emission.       
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2.10 Data Analysis and Statistics  
The experiments were performed in duplicate and repeated four times, then the 
mean of the duplicate treatments was recorded. Data was expressed as means  S.E.M. 
The data related to intracellular ROS and autophagy were not analyzed by statistics due 
to very small sample size as they were done in duplicates and repeated only two to three 
times. By contrast, the data generated by CCK and calcein assay were analyzed using 










3.1 Cell Damage caused by H2O2 or MG 
3.1.1 Hydrogen Peroxide Decreases H9c2 Cell Viability 
 The effects of H2O2 (100 - 600 M, n=4-5) on H9c2 cell viability after CCK 
assay at 1, 4, and 24 hours are shown in Figure 3.1. At a concentration of 100 M, H9c2 
cell viability remained the same as the control or slightly increased. From 300 - 600 M 
H2O2 cell viability decreased in a dose-dependent manner, but not in a time-dependent 
manner (p < 0.05 vs negative control). H2O2 600 M significantly reduced cell viability 
to 28%  3%, 30%  5%, and 17%  1% relative to the nontreated control cells (100% 
cell viability) at 1, 4, and 24 hours, respectively (p < 0.05 vs negative control). H2O2 600 
M was chosen to further test effects of autophagy enhancers or inhibitors on H2O2-
induced cell damage.  
 
Figure 3.1 H2O2 dose response on cell viability by CCK assay. H2O2 reduced cell viability in a 
dose-dependent, but not a time-dependent manner (*p < 0.05 compared to negative control). Cell 
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viability was measured at 1, 4, and 24 hours after adding increasing doses of H2O2 to the 
cardiomyoblasts.  
 
The effects of H2O2 (100 - 600 M, n=4-6) on H9c2 cell viability by calcein stain 
at 1, 4, and 24 hours are shown in Figure 3.2. Calcein stain was used as a separate test to 
confirm the CCK cell viability being that both assays determine cell viability via different 
intracellular enzymes. Calcein stain data showed that 100 - 600 M H2O2 decreased cell 
viability compared to the nontreated (negative) control in a dose-dependent but not time-
dependent manner (p < 0.05 vs negative control). H2O2 600 M significantly reduced cell 
viability to 36%  5%, 27%  1%, and 21%  2% relative to the nontreated control 
(100% cell viability) at 1, 4, and 24 hours, respectively (p < 0.05 vs negative control).  
 
Figure 3.2 H2O2 dose response on cell viability by calcein stain assay. H2O2 reduced cell viability 
in a dose-dependent, but not a time-dependent manner (*p < 0.05 compared to negative control). 
Cell viability was measured at 1, 4, and 24 hours after adding increasing doses of H2O2 to the 
cardiomyoblasts. 
 
3.1.2 Methylglyoxal Decreases H9c2 Cell Viability   
 The effects of methylglyoxal (400 M - 1200 M, n=3-5) on H9c2 cell viability 
via CCK at 1, 4, and 24 hours are shown in Figure 3.3. At a concentration of 400 M, 
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H9c2 cell viability remained the same as the control or slightly increased, so there was no 
statistical difference at 400 M MG when compared to the negative control. From 800 -
1200 M, MG significantly decreased cell viability in a dose-dependent manner but not a 
time-dependent manner compared to the negative control (p < 0.05 vs negative control). 
MG 1200 M significantly reduced cell viability to 33%  3%, 36%  7%, and 30%  
6% relative to the nontreated control (100% cell viability) at 1, 4, and 24 hours, 
respectively (p < 0.05 vs negative control). MG 1200 M was chosen to further test 
effects of autophagy enhancers or inhibitors on MG-induced cell damage.   
  
Figure 3.3 MG dose response on cell viability by CCK assay. MG reduced cell viability in a dose-
dependent, but not a time-dependent manner (*p < 0.05 compared to negative control). Cell 
viability was measured at 1, 4, and 24 hours after adding increasing doses of MG to the 
cardiomyoblasts. 
 
The effects of methylglyoxal (400 M - 1200 M, n=4-6) on H9c2 cell viability 
via calcein stain at 1, 4, and 24 hours are shown in Figure 3.4. MG concentrations 400 
M – 1200 M decreased cell viability significantly compared to the negative control in 
a dose dependent manner but not a time dependent manner (p < 0.05 vs negative control). 
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MG 1200 M significantly reduced cell viability to 33%  5%, 19%  1%, and 17%  
1% relative to the nontreated control (100% cell viability) at 1, 4, and 24 hours, 
respectively (p < 0.05 vs negative control).   
 
Figure 3.4 MG dose response on cell viability by calcein stain assay. MG reduced cell viability in 
a dose-dependent, but not a time-dependent manner (*p < 0.05 compared to negative 
control). Cell viability was measured at 1, 4, and 24 hours after adding increasing 
doses of MG to the cardiomyoblasts. 
 
3.1.3 Hydrogen Peroxide Increases Intracellular ROS in H9c2 Cells in a Dose- and 
Time-Dependent Manner 
 H2O2 (100 M - 600 M, n=2-3) increased intracellular ROS concentrations in 
H9c2 cells in a dose-dependent manner as shown in the DCFDA data in Figure 3.5. As 
portrayed in the graph, as the concentration of H2O2 increased, the level of ROS also 
increased. It can also be seen that as time increased, the concentration of ROS increased, 
especially for higher doses of H2O2, such as 500 – 600 M. At 30 minutes, 500 and 600 
M H2O2 increased intracellular ROS levels 8.14  1.58-fold and 17.69  4.52-fold, 
respectively, when compared to the negative control. Moreover, at 24 hours 600 M 
H2O2 increased intracellular ROS levels 32.54  7.47 times that of the negative control. 
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Because the experimentation was only done 2-3 times, statistical analysis was not 
performed.  
 
Figure 3.5 H2O2 dose response on intracellular ROS by DCFDA assay. H2O2 increased 
intracellular ROS levels in a dose-dependent and time-dependent manner. Cardiomyoblast 
intracellular ROS was measured from baseline – 24 hours after adding increasing doses of H2O2.   
 
3.1.4 Methylglyoxal Increases Intracellular ROS in H9c2 Cells in a Dose and Time-
Dependent Manner 
 MG (400 M - 1200 M, n=2-3) increased intracellular ROS concentrations in 
H9c2 cells in a dose- and time-dependent (0 minutes-24 hours) manner as shown in the 
DCFDA data in Figure 3.6. We saw that 400 M and 800 M actually showed very 
similar results in terms of increasing intracellular ROS. At 6 hours, 400, 800, and 1200 
M MG increased intracellular ROS levels 2.33  0.31, 2.17  0.23-fold, and 3.70  
0.91-fold respectively, when compared to the negative control. At 24 hours, 400, 800, 
and 1200 M MG increased intracellular ROS levels 4.23  0.72, 4.54  0.62-fold, and 
8.88  2.58-fold, respectively, compared to the negative control. Because the 
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experimentation was only done 2-3 times, statistical analysis did not show any significant 
effects.   
 
Figure 3.6 MG dose response on intracellular ROS by DCFDA assay. MG increased intracellular 
ROS levels in a dose-dependent and time-dependent manner. Cardiomyoblast intracellular ROS 
was measured from baseline – 24 hours after adding increasing doses of MG.   
 
3.2 Oxidative Stress and Autophagy Regulatory Drugs 
3.2.1 Hydrogen Peroxide and Trehalose 
The effects of trehalose (500 M - 100 mM, n=3-6) co-treated with H2O2 (600 
M) on H9c2 cell viability are shown in Figure 3.7. Trehalose exhibited protection 
against H2O2 in a dose- and time-dependent manner. Only the higher concentrations of 
trehalose (50 – 100 mM) showed slightly increased cell viability at 1 and 4 hours. 
However, at 24 hours, 5 mM - 100 mM trehalose significantly increased cell viability 
significantly compared to the positive control (600 M H2O2) (p < 0.05 vs positive 
control). Meanwhile, higher concentrations of trehalose showed better protection. 
Trehalose (50 mM) at 24 hours showed maximal increased cell viability (2.01  0.19 
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times that of the positive control; p < 0.05 vs positive control). The higher the y-axis 
value shown in the graph, the greater the number of viable cells in a well.  
 
Figure 3.7 Trehalose cotreatment with 600 M H2O2 effect on cell viability by CCK assay. 
Trehalose significantly increased cell viability only at 24 hours when compared to H2O2. (*p < 
0.05 compared to H2O2 (600 M) alone). Cell viability was measured at 1, 4, and 24 hours after 
adding 600 M H2O2 with increasing doses of trehalose.  
 
  
3.2.2 Methylglyoxal and Trehalose 
The effects of trehalose (500 M - 100 mM, n=4) co-treated with MG (1200 M) 
on H9c2 cell viability are shown Figure 3.8. Trehalose (5 mM - 100 mM) exhibited 
significant protection against MG-induced cell damage in a dose-dependent manner at 1, 
4, and 24 hours (p < 0.05 vs positive control). The same dose of trehalose showed similar 
cell viability at 1 and 4 hours. At 4 hours, trehalose (100 mM) increased cell viability to 
1.96  0.11 times that of the positive control (p < 0.05 vs positive control). At 24 hours, 
trehalose (5 mM) showed better fold improvement in cell viability (2.08  0.47) than the 
higher concentration (100 mM: 1.71  0.25).   
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Figure 3.8 Trehalose cotreatment with 1200 M MG effect on cell viability by CCK assay. 
Trehalose significantly increased cell viability at 1, 4, and 24 hours when compared to MG. (*p < 
0.05 compared to MG (1200 M) alone). Cell viability was measured at 1, 4, and 24 hours after 
adding 1200 M MG with increasing doses of trehalose. 
 
  
3.2.3 Hydrogen Peroxide and Rapamycin 
 The effects of rapamycin (100 nM - 20 M, n=3-5) co-treated with H2O2 (600 
M) on H9c2 cells viability are shown in Figure 3.9. All doses of rapamycin did not 
show any significant improvement in cell viability compared to the positive control at 1, 
4, and 24 hours. 
 
Figure 3.9 Rapamycin cotreatment with 600 M H2O2 effect on cell viability by CCK assay. 
Rapamycin did not show any significant increase in cell viability when compared to H2O2. Cell 
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viability was measured at 1, 4, and 24 hours after adding 600 M H2O2 with increasing doses of 
rapamycin. 
 
3.2.4 Methylglyoxal and Rapamycin 
 The effects of rapamycin (100 nM - 20 M, n=4) co-treated with MG (1200 M) 
on H9c2 cells viability are shown in Figure 3.10. Rapamycin only showed slight 
improvement in cell viability at 4 hours but not 1 or 24 hours. Moreover, the 
improvement was not dose dependent. 100 nM rapamycin was the only dosage that 
significantly increased cell viability 1.48  0.20-fold compared to the positive control (p 
< 0.05 vs positive control). 
 
Figure 3.10 Rapamycin cotreatment with 1200 M MG effect on cell viability by CCK assay. 
Rapamycin did not show significant increase in cell viability at the most doses when compared to 
H2O2 (*p < 0.05 compared to MG (1200 M) alone). Cell viability was measured at 1, 4, and 24 
hours after adding 1200 M MG with increasing doses of rapamycin. 
 
 
3.2.5 Hydrogen Peroxide and 3-Methyladenine 
 The effects of 3-methyladenine (50 M - 10,000 M, n=3-4) co-treated with H2O2 
(600 M) on H9c2 cells viability are shown in Figure 3.11. Compared to the positive 
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control (600 M H2O2), there were no significant increases in cell viability at any dose of 
3-MA at 1, 4, or 24 hours. 
   
 
Figure 3.11 3-MA cotreatment with 600 M H2O2 effect on cell viability by CCK assay. 3-MA 
did not show any significant increase in cell viability when compared to H2O2. Cell viability was 
measured at 1, 4, and 24 hours after adding 600 M H2O2 with increasing doses of 3-MA.   
 
3.2.6 Methylglyoxal and 3-methyladenine 
 The effects of 3-methyladenine (50 M - 10,000 M, n=3-4) co-treated with MG 
(1200 M) on H9c2 cells viability are shown in Figure 3.12. 3-MA showed improved 
cell viability at 1 and 4 hours, but not 24 hours. Moreover, the protection was dose 
independent. At a concentration of 10,000 M 3-MA, cell viability was increased 1.43  
0.26 and 1.43  0.09 times that of the positive control at 1 and 4 hours, respectively, (p < 
0.05 vs positive control). 
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Figure 3.12 3-MA cotreatment with 1200 M MG effect on cell viability by CCK assay. 3-MA 
significantly increased cell viability at 1 and 4 hours but not 24 hours when compared to MG. (*p 
< 0.05 compared to MG (1200 M) alone). Cell viability was measured at 1, 4, and 24 hours after 
adding 1200 M MG with increasing doses of 3-MA. 
 
 
 3.3 Reactive Oxygen Species and Autophagy Regulatory Drugs 
3.3.1 Reactive Oxygen Species of H9c2 Cells exposed to H2O2 and Trehalose  
 The effects of trehalose (500 M and 100 mM, n=2-3) co-treated with H2O2 (600 
M) on ROS levels of H9c2 cells are shown in Figure 3.13. H2O2 600 M started to 
increase intracellular ROS levels at 30 min and continued throughout 24 hours when 
compared to nontreated control. By contrast, trehalose (500 M and 100 mM) showed a 
trend to reduce H2O2-induced increase in ROS from 30 min to 24 hours. At 24 hours, 
H2O2 (600 M) increased intracellular ROS levels 32.54  7.47-fold when compared 
nontreated control. The higher the y-axis value in the DCFDA graph, the greater the 
amount of intracellular ROS. Trehalose (500 M and 50 mM) reduced intracellular ROS 
levels to 21.75  6.99 and 25.71   7.74, respectively, when compared to 600 M H2O2 
alone. However, because of a small sample size, no statistics was able to be completed.     
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Figure 3.13 Trehalose cotreatment with 600 M H2O2 effect on intracellular ROS by DCFDA 
assay. Trehalose showed a trend to reduce intracellular ROS levels when compared to H2O2. 
Cardiomyoblast intracellular ROS was measured from baseline – 24 hours after adding 600 M 
H2O2 with increasing concentrations of trehalose.   
 
3.3.2 Reactive Oxygen Species of H9c2 Cells exposed to MG and Trehalose  
 The effects of trehalose (500 M - 100 mM, n=2-3) co-treated with MG (1200 
M) on ROS levels in H9c2 cells are shown in Figure 3.14. MG 1200 M started to 
increase intracellular ROS levels at 2 hour and continued to raise it through 24 hours 
when compared to nontreated control. By contrast, the lower dose of trehalose (500 M) 
but not the higher dose of trehalose (100 mM) showed a trend to reduce MG-induced 
increase in ROS from 2 hour to 24 hours. At 24 hours, MG (1200 M) increased 
intracellular ROS levels 8.88  2.58 times that of the nontreated control. By contrast, 
trehalose (500 M) increased intracellular ROS levels only 3.75  1.15 times that of the 
nontreated control. Therefore, trehalose (500 M) decreases intracellular ROS compared 
to 1200 M MG alone at 24 hours.  
36 
 
Figure 3.14 Trehalose cotreatment with 1200 M MG effect on intracellular ROS by DCFDA 
assay. Trehalose showed a trend to reduce intracellular ROS levels only at lower concentration 
when compared to MG. Cardiomyoblast intracellular ROS was measured from baseline – 24 
hours after adding 1200 M MG with increasing concentrations of trehalose.    
 
3.3.3 Reactive Oxygen Species of H9c2 Cells exposed to H2O2 and Rapamycin 
 The effects of rapamycin (100 nM - 20 M, n=2-3) co-treated with H2O2 (600 
M) on ROS levels in H9c2 cells are shown in Figure 3.15. H2O2 600 M started to 
increase intracellular ROS levels at 30 min and continued to raise it through 24 hours 
when compared to nontreated control.  By contrast, rapamycin (100 nM and 20 M) 
showed a trend to reduce H2O2-induced increase in ROS from 30 min to 24 hours. The 
reduction was dose dependent. At 24 hours, rapamycin (100 nM and 20 M) reduced 
intracellular ROS levels to 27.32  5.29 and 18.18  5.19, respectively, when compared 
to 600 M H2O2 alone.  
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Figure 3.15 Rapamycin cotreatment with 600 M H2O2 effect on intracellular ROS by DCFDA 
assay. Rapamycin showed a trend to reduce intracellular ROS levels when compared to H2O2. 
Cardiomyoblast intracellular ROS was measured from baseline – 24 hours after adding 600 M 
H2O2 with increasing concentrations of rapamycin.    
 
3.3.4 Reactive Oxygen Species of H9c2 Cells exposed to MG and Rapamycin  
 The effects of rapamycin (100 nM - 20 M, n=2-3) co-treated with MG (1200 
M) on ROS levels in H9c2 cells are shown in Figure 3.16. MG (1200 M) started to 
increase intracellular ROS levels at 2 hour and continued to raise it through 24 hours 
when compared to nontreated control. By contrast, rapamycin (100 nM and 20 M) 
showed a trend to reduce MG-induced increase in ROS from 6 to 24 hours. At 24 hours, 
in the presence of MG (1200 M), rapamycin (100 nM and 20 M) increased 
intracellular ROS levels 6.29  1.69-fold and 6.80  1.93-fold, respectively, when 
compared to nontreated control, whereas MG (1200 M) alone increased intracellular 
ROS levels 8.88  2.58 times that of the nontreated control.           
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Figure 3.16 Rapamycin cotreatment with 1200 M MG effect on intracellular ROS by DCFDA 
assay. Rapamycin showed a trend to reduce intracellular ROS levels at 24 hours when compared 
to MG. Cardiomyoblast intracellular ROS was measured from baseline – 24 hours after adding 
1200 M MG with increasing concentrations of rapamycin.    
 
3.3.5 Reactive Oxygen Species of H9c2 Cells exposed to H2O2 and 3-methyladenine 
 The effects of 3-methyladenine (50 M - 10,000 M, n=2-3) co-treated with H2O2 
(600 M) on ROS levels in H9c2 cells are shown in Figure 3.17. H2O2 600 M started to 
increase intracellular ROS levels at 30 min and continued to raise them through 24 hours 
when compared to nontreated control ROS levels. The lower dose of 3-MA (50 M) 
showed a slight trend to reduce H2O2-induced increase in ROS from 30 min to 24 hours 
based on the preliminary data. By contrast, the higher dose 3-MA (10,000 M) showed a 
slight increase in ROS from 30 min to 24 hours. At 24 hours, the ROS levels were 
increased 32.54  7.47, 29.92  7.21, and 34.32  3.19-fold for 600 M H2O2, 50 M 3-
MA, and 10,000 M 3-MA, respectively. The higher the y-axis value, the greater the 
levels of intracellular ROS.             
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Figure 3.17 3-MA cotreatment with 600 M H2O2 effect on intracellular ROS by DCFDA assay. 
3-MA showed no obvious effects on intracellular ROS levels when compared to H2O2. 
Cardiomyoblast intracellular ROS was measured from baseline – 24 hours after adding 600 M 
H2O2 with increasing concentrations of 3-MA.    
 
3.3.6 Reactive Oxygen Species of H9c2 Cells exposed to MG and 3-methyladenine  
 The effects of 3-methyladenine (50 M - 10,000 M, n=2-3) co-treated with MG 
(1200 M) on ROS levels of H9c2 cells are shown in Figure 3.18. MG (1200 M) 
started to increase intracellular ROS levels at 2 hour and continued to raise them through 
24 hours when compared to the nontreated control. By contrast, 3-MA (50 M - 10,000 
M) showed slight reduction in MG-induced ROS increase only at 24 hours, based on the 
preliminary data. The ROS levels were increased 8.88  2.58, 7.55  1.38, and 6.97  
1.56-fold for 1200 M MG, 50 M 3-MA cotreatment, and 10,000 M 3-MA 
cotreatment, respectively, at 24 hours. 
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Figure 3.18 3-MA cotreatment with 1200 M MG effect on intracellular ROS by DCFDA assay. 
3-MA showed slight reduction of intracellular ROS levels at 24 hours when compared to MG. 
Cardiomyoblast intracellular ROS was measured from baseline – 24 hours after adding 1200 M 
MG with increasing concentrations of 3-MA.    
 
3.4 The effects of H2O2 and MG on Autophagy Rate 
3.4.1 Effects of H2O2 on autophagy rate 
 The effects of H2O2 (100 M - 600 M, n=2) on autophagy are shown in Figure 
3.19. The greater the y-axis value, the greater the number of autophagosomes present in 
the cell, therefore indicating higher levels of autophagy occurring. The preliminary data 
showed that H2O2 increased autophagy in a dose dependent manner only at 1 and 4 hours. 
Moreover, the same dose of H2O2 induced higher autophagy levels at 1 hour compared to 
4 hours. By contrast, at 24 hours, lower doses (100 M and 300 M) showed a similar 
autophagy level increase as 1 hour whereas higher dose ranges (500 M and 600 M) 
reduced autophagy almost to the basal autophagy level. At 1, 4, and 24 hours, 300 M 
H2O2 increased autophagy 1.72  0.59, 1.14  0.14, and 1.76  0.63-fold, respectively, 
when compared to the negative control. By contrast, 600 M H2O2 increased the 
41 
autophagy rate 2.30  1.31, 1.96  0.89, and 1.07  0.26-fold, respectively, when 
compared to the negative control.  
 
Figure 3.19 H2O2 dose response on autophagy rate by Cyto ID assay. H2O2 dose-dependently 
increased autophagy level at 1 and 4 hours but not at 24 hours. Autophagy level was measured at 
1, 4, and 24 hours after adding increasing concentrations of H2O2 to the cardiomyoblasts.  
 
3.4.2 Effects of MG on autophagy rate 
The effects of MG (400 M - 1200 M, n=2) on autophagy are shown in Figure 
3.20. The greater the y-axis value, the greater the number of autophagosomes present in 
the cell, therefore indicating higher levels of autophagy occurring. The preliminary data 
showed that MG (400 M - 1200 M) increased autophagy in a dose- and time-
dependent manner only at 1and 24 hours when compared to the nontreated control. By 
contrast, there was no change in autophagy rate by MG at 4 hours. At 24 hours, 
autophagy was increased 1.39  0.15, 1.84  0.68, and 1.69  0.75-fold for 400 M MG, 
800 M MG, and 1200 M MG, respectively, when compared to the nontreated control.           
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Figure 3.20 MG dose response on autophagy rate by Cyto ID assay. MG increased autophagy 
level in a dose-dependent and time-dependent manner. Autophagy level was measured at 1, 4, 





Our studies showed that both H2O2 and MG reduce H9c2 cell viability in a dose-
dependent manner. The reduction of cell viability correlated with increased intracellular 
ROS levels. Also, preliminary Cyto ID data suggests that autophagy was induced by 
H2O2 or MG. The autophagy enhancing drug trehalose showed to have protective effects 
on H9c2 cells exposed to H2O2 at 24 hours only. However, trehalose protected cells 
against MG-induced cell damage at 1, 4, and 24 hours. Rapamycin, another autophagy 
enhancer, did not provide protection against H2O2. By contrast, only the low dose of 
rapamycin (100 nM) at 4 hours slightly increased the cell viability against MG-induced 
cell damage. Both trehalose and rapamycin reduced intracellular ROS levels induced by 
H2O2 or MG. By contrast, 3-MA, an autophagy inhibitor, also did not provide any 
increased cell viability to H9c2 cells exposed to H2O2. However, 3-MA did show 
protection against MG at 1 and 4 hours, but not 24 hours. 3-MA did not show any 
reduction in intracellular ROS levels induced by H2O2 or MG. 
4.1 H2O2 and MG induced H9c2 cell damage and autophagy changes 
4.1.1 H2O2 caused cell damage and autophagy rate increased  
  H2O2 often causes cell damage by forming ROS in the cell’s mitochondria, 
therefore increasing the level of intracellular ROS. This occurs when superoxide species 
form in the mitochondria when free electrons escape the ETC and combine with O2 
forming superoxide. Superoxide dismutase then converts superoxide to H2O2. H2O2 
would then normally be converted into H2O by catalase; however, under disease 
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conditions H2O2 is produced at a faster rate than catalase can convert it to water. H2O2 is 
then converted to hydroxyl radicals, which are very reactive molecules; they can interact 
with cellular DNA, lipids, and proteins disrupting normal cellular function (Phaniendra et 
al, 2015). The CCK and calcein stain testing we conducted resulted in H2O2 reducing 
H9c2 cell viability in a dose-dependent manner from 100 µM – 600 µM with 600 µM 
H2O2 decreasing cell viability to about 60-80% compared to the nontreated control. The 
results we found were consistent with a study by Chen et al, 2000, which showed that 
H2O2 (200 – 600 µM) increased the percentage of dead H9c2 cells in a dose-dependent 
manner. The study determined that at 24 hours, 600 µM H2O2 increased the percentage of 
dead cells to 60% compared to the nontreated control (Chen et al, 2000). 
 As previously mentioned, H2O2 damages the cell leading to a decrease in cell 
viability by increasing intracellular ROS that damage important cellular DNA and 
proteins. In our experimentation we found that H2O2 increased intracellular ROS in a 
dose- and time-dependent manner, which was measured using DCFDA assay. Our study 
was confirmed by a study done by Amri et al, 2017 which tested how neuroglobin 
protected astroglial cells from oxidative stress caused by H2O2. Their study found that 
when astroglial cells were exposed to H2O2 (50 – 300 µM), the cellular ROS levels 
increased as the dose of H2O2 increased as well as when the exposure time to H2O2 
increased (Amri et al, 2017). 
 Cells under oxidative stress through the increase of H2O2 will undergo the process 
of autophagy to try to decrease the damage of important cellular macromolecules caused 
by intracellular ROS. A vacuole called an autophagosome is formed by the signaling of 
Ulk-1 under oxidative stress. The autophagosome collects damaged proteins, lipids, 
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DNA, etc. and then fuses with a lysosome forming an autolysosome. The autolysosome 
then breaks down the damaged components into their monomeric form for the cell to be 
able to recycle and rebuild new functioning DNA, proteins, and lipids (Glick et al, 2010). 
H2O2 induces autophagy in cells by activation of AMP-activated protein kinase (AMPK). 
AMPK regulates the cell when the cell is under stress conditions; AMPK activation is 
necessary in order for the cell to survive. AMPK induces autophagy in cells by directly 
phosphorylating Ulk-1, which then activates Ulk-1 and signals for the autophagosome to 
form (She et al, 2014 and Viollet et al, 2011). A study done by She et al, 2014 
experimented how AMPK protects against H2O2-induced apoptosis in osteoblasts. By use 
of Western blotting for AMPK, She found that AMPK activation depended on dose of 
H2O2 (100 – 250 µM) and exposure time (0 – 2 hours) to H2O2 (She et al, 2014).  
In our study, we examined the levels of autophagy in H9c2 cells exposed to H2O2 
by using Cyto ID, which detects autophagy levels in viable cells by determining the 
number of autophagosomes present. For H9c2 cells exposed to 100 – 600 µM H2O2, we 
saw that the rate of autophagy increased in a dose-dependent manner for 1 and 4 hours. 
For 24 hours we saw that the peak autophagy rate occurred at 300 µM H2O2, then the rate 
decreased from 500 – 600 µM. Our results of H2O2 increasing the rate of autophagy was 
correlated with a study done by Danyoung Li and Jingcheng Yu that studied how 
autophagy appeases oxidative stress in Mc3T3-E1 osteoblasts. In their study they 
determined that H2O2 (0 mM – 1mM) increased the rate of autophagy. Western blot 
results showed that as the dose of H2O2 was increased, the expression of autophagy-
related proteins Beclin-1 and LC3II were increased in the osteoblasts, and MDC staining 
determined that the number of autophagosomes increased as the concentration of H2O2 
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increased (Li et al, 2017). We suggest that 24 hours has a slight decrease in the rate of 
autophagy after 300 µM H2O2 because at 500 - 600 µM H2O2, 60-80% of the cells are 
already dead compared to the nontreated control, based on the CCK data, and the Cyto ID 
analysis measures autophagy in viable cells only. If there are less viable cells at 24 hours, 
this will in turn display a lower level of autophagy occurring. Autophagy has also been 
shown to be known as a double-edged sword meaning that autophagy is capable of 
helping the cell under times of stress but can also damage the cell if there is too much 
stress. A study by Eileen White and Robert DiPaola discussed how autophagy is a 
double-edged sword in cancer and can be both beneficial and detrimental to cells. The 
study found that over stimulating autophagy by over-expressing Beclin-1 suppressed 
tumorigenesis. Over stimulation of autophagy occurs if the cell is under excessive 
oxidative stress; the cell then over-consumes DNA, lipids, and proteins providing more 
harm to the cell than benefit (White and DiPaola, 2009).  
4.1.2 MG caused cell damage and autophagy rate increased  
MG causes cell damage by increasing dicarbonyl stress. MG is a glycating agent 
that is formed as a by-product of metabolic processes, such as glycolysis. MG forms 
advanced glycation end products that can react with proteins and other cellular 
components, therefore altering and decreasing their function inducing cellular damage 
(Allaman et al, 2015 and Thornalley, 2008). Our CCK and calcein stain assays with MG 
showed that as the concentration of MG increases (400 µM – 1200 µM), cell viability 
decreases. 1200 µM MG decreased cell viability to about 60-80% compared to the 
nontreated control. Our study was complemented by a study performed by Seo et al, 
2014. Seo actually performed the experimentation on HepG2 liver cells and with higher 
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doses of MG than in our study, but the results were similar in that MG dose-dependently 
decreased HepG2 cell viability. In their study, cell viability was assessed under MG 
concentrations of 1 mM – 10 mM, and 10 mM MG decreased cell viability the most 
when compared to the nontreated control (Seo et al, 2014). 
We speculate the reason cell viability decreases is because MG raises the level of 
dicarbonyl stress in the cell by increasing intracellular ROS over physiological levels, 
which causes an increase in damage to the cell’s DNA, lipids, and proteins. MG can 
cause increases in intracellular ROS by disrupting mitochondrial proteins that function as 
antioxidant mechanisms. For example, the advanced glycation end products formed from 
MG disrupt the function of superoxide dismutase and reduce the activity of catalase, both 
of which are important antioxidant enzymes (Desai et al, 2010 and Chen et al, 2018). In 
our study we used DCFDA assay, which measures intracellular ROS and determined that 
MG increased intracellular ROS in a dose- and time- dependent manner. Compared to a 
nontreated control, as the concentration of MG increased from 400 µM – 1200 µM, the 
level of ROS increased. As mentioned before, Seo, performed their experimentation on 
HepG2 liver cells and with higher doses of MG than in our study. Their study also 
examined intracellular ROS levels using DCFDA. Even though their study experimented 
with higher doses of MG (1 mM – 10 mM), their DCFDA results depicted higher ROS 
levels as the dose of MG was increased. However, their study did not include the factor 
of time since their DCFDA data was all collected at 12 hours (Seo et al, 2014).  
Due to the increased damage caused by MG increasing intracellular ROS, the 
autophagy rate will also be increased. MG induces autophagy in a similar manner that 
H2O2 increases the rate of autophagy, by increasing AMPK activation (Dafre et al, 2017). 
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A study done by Dafre et al, 2017 tested how MG-induced activation led to autophagy 
degradation of thioredoxin 1 and glyoxalase 2 in HT22 nerve cells. Their results showed 
that AMPK phosphorylation occurred by MG in a dose- (0 - 0.5 mM) and time- (1 – 18 
hours) dependent manner. Activation of AMPK resulted in inactivation of mTOR and 
therefore increased autophagy by phosphorylation of Ulk-1 (Dafre et al, 2017). In our 
study, using Cyto ID we found that the rate of autophagy increases as the concentration 
of MG (400 – 1200 µM) increases at 1 and 24 hours. Interestingly, 4 hours seems to not 
have that much of an increase in autophagy compared to the nontreated control. We 
actually do not have a firm explanation for why this has occurred; more Cyto ID testing is 
required. We can see based on the DCFDA data of MG that it does take time to produce 
sufficient ROS levels in the cardiomyocytes, which is why we see 24 hours containing 
the highest rate of autophagy, but why 1 hour shows a higher rate of autophagy than 4 
hours is not understood as of yet. However, we do know based on previous studies that 
MG does increase the rate of autophagy. A study by Yo-Chen Chang et al, 2015 tested 
how MG increased the rate of autophagy and suppressed cell division in human retinal 
pigment ARPE-19 epithelial cells. This study also came to conclude that MG increased 
the autophagy flux in the epithelial cells. When treated with MG (125 µM – 500 µM) 
Western blot showed that the epithelial cells showed an increased production of LC3II as 
the dose of MG increased. The experiment also looked at 250 µM MG at different times 
(0 – 24 hours) to determine if exposure time would increase the autophagy flux. Results 
showed that exposure to 250 µM MG increased the presence of LC3II as exposure time 
was increased, based on Western blot analysis (Chang et al, 2015). 
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4.2 Trehalose effects on cell viability and intracellular ROS in H9c2 cells exposed to 
H2O2 or MG 
Trehalose is a disaccharide sugar not found in mammals (Hosseinpour-
Moghaddam et al, 2018), but when introduced to mammals trehalose works as an 
autophagy enhancer. Trehalose enhances autophagy by inhibiting glucose and fructose 
from entering the cell; this induces a starvation-like state in the cell which then signals 
for autophagy to occur by stimulation of AMPK and activation of the Ulk-1 complex 
(Mardones, Rubinsztein, and Hetz, 2016).  
Trehalose also is capable of reducing intracellular ROS levels by upregulating the 
Kelch-like ECH-associated protein 1- NF-E2 related factor 2 (Keap1-Nrf2) pathway 
(Mizunoe et al, 2018). Nrf2 is important in regulating antioxidant mechanisms in the cell 
to reduce ROS. Nrf2 controls the gene expression of enzymes involved in eliminating 
ROS. When a cell is under oxidative stress conditions, the cell alters metabolism and 
gene expression to maintain redox homeostasis; it does so by activating Nrf2 as well as 
other stress response pathways. Keap1 acts as a regulatory protein of Nrf2; under 
unstressed conditions, Keap1 ubiquitinates Nrf2 (Kasai et al, 2020). A study by Mizunoe 
et al, 2018 showed how trehalose protects against oxidative stress by regulation of 
Keap1-Nrf2. Results showed that trehalose upregulated Nrf2 genes and therefore 
decreased intracellular ROS via antioxidant mechanism. In their study, when compared to 
paraquat, which is an experimental ROS generator, trehalose (50 mM) reduced 
intracellular ROS when analyzed by DCFDA (Mizunoe et al, 2018).  
In our study when trehalose (500 µM – 100 mM) was introduced to cells exposed 
to H2O2 (600 µM) we found that cell viability increased at 24 hours; however, at 1 and 4 
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hours there did not seem to be any increase in cell viability compared to H2O2 (600 µM). 
We also determined that trehalose decreased intracellular ROS in H9c2 cells exposed to 
H2O2 (600 µM) compared to H9c2 cells exposed to H2O2 (600 µM) alone. Our DCFDA 
analysis was only done two times, so statistical analysis was not able to conclude any 
significance; this experimentation will need to be done a few more times in the future. 
However, based on the experiments we have done, we do see that the lower dose of 
trehalose (500 µM) and the higher dose of trehalose (100 mM) both decrease intracellular 
ROS compared to the positive control (600 µM H2O2). 
In our experiment of trehalose with MG, we found that trehalose (500 µM – 100 
mM) increased cell viability in H9c2 exposed to MG (1200 µM) at 1, 4, and 24 hours 
compared to the positive control (MG 1200 µM). The highest increase in cell viability 
occurred at 24 hours with exposure to 5 mM trehalose; the cell viability then decreased 
from 10 – 100 mM trehalose. It’s possible that the decrease in cell viability from 10 – 100 
mM trehalose at 24 hours occurs because if a cell is under stress and too much autophagy 
occurs, then there is too much self-consumption further damaging the cell leading to cell 
death as mentioned before with autophagy being a double-edged sword. DCFDA data for 
trehalose with MG shows that the lower dose of trehalose (500 µM) decreases 
intracellular ROS more than the higher dose of trehalose (100 mM) when compared to 
the positive control. Our DCFDA data shows that at 24 hours 100 mM trehalose 
cotreatment has intracellular ROS levels similar to the positive control therefore the H9c2 
cells are under sufficient stress, so enhancing autophagy could be overkill for the cell 
causing the decrease in cell viability. 
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Our study on trehalose with H2O2 increasing cell viability was correlated with a 
study done by Darabi et al, 2018 who experimented on how trehalose activates autophagy 
to prevent H2O2-induced cell death in bone marrow stromal cells. The study found that 
after 8 hours H2O2 decreased cell viability to 82%, 72%, 49%, and 39% of the control 
after receiving 50, 100, 200, and 400 µM of H2O2, respectively. However, with 
pretreatment of trehalose 3% for 2 hours before exposure to H2O2, the cells increased cell 
viability to 92%, 84%, 75%, and 48% of the control after receiving 50, 100, 200, and 400 
µM of H2O2, respectively (Darabi et al, 2018). Also, our study of trehalose decreasing 
intracellular ROS compared to a study done by Gao et al, 2018, which experimented on 
how trehalose reduced damage caused by H2O2 in dopaminergic SH-SY5Y cells. Using 
DCFH-DA Gao was able to determine how trehalose affected the level of ROS produced 
by H2O2 in the SH-SY5Y cells. To test this, the cells were pretreated with 5mM trehalose 
for 48 hours, then the cells were incubated with H2O2 (250 µM or 500 µM) for 6 hours. 
The results showed that trehalose inhibited H2O2-induced increases of ROS in SH-SY5Y 
cells, therefore maintaining the proper function of antioxidant enzymes such as 
superoxide dismutase and catalase (Gao et al, 2018).     
4.3 Rapamycin effects on cell viability and intracellular ROS in H9c2 cells exposed 
to H2O2 or MG 
Rapamycin is a natural drug that possesses strong antifungal and 
immunosuppressant properties. It is an autophagy enhancer that works by binding 
FKBP12 protein and forming a complex that inhibits mTOR, which is a regulatory 
protein of autophagy that inhibits the process of autophagy. Rapamycin inhibits mTOR 
and increases Ulk-1 activity, which therefore signals for autophagy to proceed (Yang et 
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al, 2013). There are two complexes of mTOR, mTORC1 and mTORC2. Rapamycin 
directly inhibits mTORC1; however, rapamycin needs chronic administration to inhibit 
mTORC2 in some cell lines. The ability of a cell to respond to treatment of rapamycin 
depends on the expression of FKBP12; reduction of FKBP12 levels in cell lines can 
block rapamycin’s ability to inhibit mTORC1 and mTORC2 (Schreiber et al,2015).  
Our study showed that rapamycin (100 nM – 20 µM) did not increase cell 
viability compared to the positive control (600 µM H2O2). Looking at our DCFDA data 
we saw that both the low dose of rapamycin (100 nM) and the high dose of rapamycin 
(20 µM) decreased intracellular ROS compared to the positive control (600 µM H2O2), so 
we expected to see that cell viability would also increases since the oxidative stress is 
reduced in those cells. Our study was countered by a study by Gao et al, 2020 that 
experimented with the effects of rapamycin on rat H9c2 cardiomyocytes with chronic 
heart failure. Results of this study found that rapamycin improved cardiomyocyte 
function by promoting autophagy in rats with heart failure. Using Western blotting, Gao 
found that rapamycin inhibited caspase-3 expression, which is important for the process 
of apoptosis, and upregulated important autophagy proteins, LC3 II, Beclin-1, and p62. 
Gao also explored the mechanism by which rapamycin inhibits mTOR in rats with 
chronic HF. Gao looked at the activities of mTORC1 and mTORC2 as denoted by 
phosphorylation of their targets downstream S6 and Akt, respectively. Results showed 
that rapamycin inhibited the phosphorylation of S6 and Akt therefore promoting 
autophagy (Gao et al, 2020). However, the concentration of rapamycin (1.4 mg-kg-day) 
and the time period of administration (8-12 weeks) were higher and longer than the 
concentrations and times used in our study.   
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Another study by Ding et al, 2017 used concentrations of rapamycin similar to 
what we used for our experimentation and found that rapamycin is actually detrimental to 
cardiac myocytes in rats. Results showed that rapamycin (1 nM – 100 µM) reduced cell 
survival rate compared to a nontreated control. In this study, rapamycin’s ability to 
induce autophagy caused cardiac myocyte death (Ding et al, 2017). The findings of this 
study seem to support our own data, which indicate that rapamycin (100 nM – 20 µM) 
did not increase cell viability in cells treated with 600 µM H2O2. However, because of the 
conflicting data found when comparing research studies, as well as the conflicting data in 
our own studies, it is clear that more experiments will need to be done with rapamycin on 
H9c2 cell viability and intracellular ROS levels.  
In our experiment of rapamycin (100 nM – 20 µM) with H9c2 cells exposed to 
MG (1200 µM), we can see that there is only one dose of rapamycin (100 nM) at 4 hours 
that shows a significant increase in cell viability compared to the positive control (1200 
µM MG). Other than the one dose, rapamycin does not seem to increase cell viability in 
the cardiomyocytes. The DCFDA data also does not show much reduction in intracellular 
ROS levels when either 100 nM or 20 µM rapamycin are added compared to 1200 µM 
MG. 
Rapamycin has been found to increase glycolytic intermediates, such as G6P and 
DHAP among others (Tucci et al, 2013). An increase in DHAP and GP6 would mean an 
increase in MG formation, which could contribute to the lack of increased cell viability 
by rapamycin. Tucci et al, 2013 also tested the effects of rapamycin on glutathione, 
which is an important antioxidant path in cells. Results showed a possible increase in 
glutathione when rapamycin was introduced into rat fibroblast cells (Tucci et al, 2013). 
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Another study by Shin et al, 2011 did find that rapamycin protected human corneal 
endothelial cells by reducing intracellular ROS by increasing intracellular glutathione 
(Shin et al, 2011). This could explain why in our study we saw decreases in intracellular 
ROS compared to our positive controls; however, more experimentation with rapamycin 
will need to be done.  
4.4 3-methyladenine effects on cell viability and intracellular ROS in H9c2 cells 
exposed to H2O2 or MG 
3-methyladenine is an autophagy inhibitor that works by inhibiting class III PI3K 
complex. This then blocks PI3K from forming, which would normally recruit Atg 
proteins for the initiation of autophagy (Wu et al, 2010). As we expected, our study 
shows that introducing 3-MA with H2O2 (600 µM), 3-MA (50 – 10,000 µM) does not 
provide any increased cell viability compared to the positive control (600 µM H2O2), and 
DCFDA data shows that 3-MA does not decrease intracellular ROS. The higher dose of 
3-MA (10,000 µM) increases intracellular ROS slightly higher than the positive control. 
When introducing 3-MA with MG (1200 µM) we found that 3-MA (50 – 10,000 µM) 
increased cell viability at 1 and 4 hours compared to the positive control (1200 µM MG); 
24 hours did not show any increased cell viability. The DCFDA data showed that from 
baseline – 6 hours 3-MA (50 µM or 10,000 µM) did not reduce intracellular ROS 
compared to the positive control; at 24 hours there was a slight decrease in intracellular 
ROS by both the low dose and high dose of 3-MA compared to the positive control.    
We speculate that 3-MA provides protection for MG but not for H2O2 because 3-
MA has been shown to have a dual role as demonstrated by Wu et al, 2010. Wu et al, 
2010 has shown that 3-MA induced autophagy under nutrient-rich conditions. 3-MA 
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works by inhibiting PI3K, which of there are two classes of: class I PI3K and class III 
PI3K. 3-MA targets both of these without discrimination. Inhibition of class III PI3K will 
prevent autophagy from occurring; however, inhibition of class I PI3K promotes 
autophagy. Under nutrient-rich conditions, 3-MA seemed to inhibit class I PI3K, while 
the function of class III PI3K was preserved therefore promoting autophagy (Wu et al, 
2010). In our study we see that 600 µM H2O2 increases intracellular ROS rather quickly, 
therefore causing stress in the cell and possibly inducing a nutrient-deficient state rapidly. 
As discussed in the study by Wu, in a nutrient-deficient state, 3-MA does not induce 
autophagy, which is why we believe we do not see an increase in cell viability in our 
study. Meanwhile, MG does not induce oxidative stress as quickly as H2O2; our DCFDA 
data shows that the highest levels of intracellular ROS occur at 24 hours, so we speculate 
that at 1 and 4 hours there is still viable nutrients that the cell can receive, therefore 
allowing 3-MA to inhibit class I PI3K instead of class III PI3K consequently promoting 
autophagy. Then at 24 hours, enough time has passed for MG to induce oxidative stress 
and starve the cell of sufficient nutrients preventing 3-MA from promoting autophagy 
and increasing cell viability.   
A study by Shin et al, 2014 correlates with our study’s findings that 3-MA 
increases intracellular ROS levels. Shin did a study on the relationship between ROS and 
autophagy in mouse blastocysts. Results of the study found that daily injections of 5 mM 
3-MA increased intracellular ROS levels in the blastocysts (Shin et al, 2014).   
4.5 Future Studies  
In the future it will be required for us to do more DCFDA testing since all of our 
DCFDA experiments were run just 2-3 times. Cyto Id analysis for measuring autophagy 
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will also need to be run again since that experimentation was also done only twice. For 
Cyto ID we think it will be beneficial in the future to examine the autophagy rates with 
the autophagy regulatory drugs we used, since we had only done dose response Cyto ID 
experimentation on H2O2 and MG. More experimentations will need to be done on 
rapamycin to evaluate more on why ROS was decreased, but cell viability did not 
decrease. We also find it important to choose another autophagy inhibitor besides 3-MA 
to test the effects of cell viability and intracellular ROS levels, since 3-MA has a dual 
role; by picking an inhibitor that does not seem to have a dual role, such as chloroquine, 
we can perhaps get a better understanding of the role of an autophagy inhibitor and also 
use chloroquine as a comparison to 3-MA.    
4.6 Conclusion 
 In conclusion we determined that H2O2 and MG decrease cell viability and 
increase intracellular ROS of H9c2 cells in a dose-dependent manner. The autophagy 
enhancing drug trehalose increased cell viability of H9c2 cells exposed to H2O2 at 24 
hours, and increased cell viability of cells exposed to MG at 1, 4, and 24 hours by 
decreasing intracellular ROS. Rapamycin, another autophagy enhancer, which although 
decreased intracellular ROS, did not increase cell viability in cells exposed to H2O2, and 
for cells exposed to MG, only the low dose of rapamycin at 4 hours provided an increase 
in cell viability. 3-methyladenine, an autophagy inhibitor, did not provide decreases in 
intracellular ROS and therefore did not increase cell viability of H9c2 cells exposed to 
H2O2. For H9c2 cells exposed to MG, we saw 3-MA increased cell viability at 1 and 4 
hours although intracellular ROS was not decreased. For autophagy rate of H2O2, we saw 
the autophagy rate increased in dose-dependent manner at 1 and 4 hours, but at 24 hours, 
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the autophagy rate peaked at 300 µM, then decreased at doses higher than that. For MG, 
the autophagy rate increased in a dose-dependent manner at 1 and 24 hours, but at 4 
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